-
Posted by
Two Blokes Thu at 11:30 PM -
Filed in
Stock
-
0 views
Travere Therapeutics (TVTX) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $1.76 per share a year ago.
